Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Flixonase

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
BACKGROUND Various studies have investigated the efficacies of mometasone furoate monohydrate (MFM) and fluticasone propionate… Expand
Is this relevant?
2013
2013
Objective To use the MORA bio-resonance therapy system combined with Flixonase for treatment perennial allergic rhinitis and… Expand
Is this relevant?
2011
2011
  • 2011
Fluticasone is a locally acting potent corticosteroid and is registered in the Netherlands since 1990. It is marketed as nasal… Expand
  • table 1
  • table 2
Is this relevant?
2010
2010
Objective to compare the efficacy of azelastine hydrochloride nasal spray and fiixonase in treating perennial allergic rhinitis… Expand
Is this relevant?
2009
2009
Objective To investigate the effect of combination of fluticasone and salmeterol on the expression of IL-4、8、12、13,airway… Expand
Is this relevant?
2008
2008
  • 2008
Fluticasone propionate is a locally acting potent corticosteroid and is registered in the Netherlands since November 1990. It is… Expand
  • table 1
Is this relevant?
Review
2003
Review
2003
Although response to intranasal steroid therapy has been reported in patients with allergic rhinitis, efficacy of some nasal… Expand
  • table 2
  • table 1
Is this relevant?
2002
2002
Objective To assess the efficacy of flixonase (fluticasone propionate) aqueous nasal spray (a patent product of Glaxo Smithkline… Expand
Is this relevant?
2000
2000
The rheological profiles of commercial corticosteroid nasal spray suspensions (Beconase, Nasacort, Flixonase, and Nasonex) were… Expand
Is this relevant?
2000
2000
The rheological profiles of four commercial nasal spray suspensions (Beconase, Flixonase, Nasacort and Nasonex) were compared… Expand
Is this relevant?